Elliott Levy, MD, is a drug developer and clinical trialist with extensive experience in the pharmaceutical industry. They served as a Strategic Advisor at LianBio from 2022 to 2025 and held multiple senior leadership roles at Bristol-Myers Squibb between 2010 and 2014. Currently, Elliott is a Venture Partner at 5AM Ventures and an Independent Director at several organizations including Omega Therapeutics, NuCana plc, and Editas Medicine. They also contribute as a Senior Advisor at Boston Consulting Group and as a member of the Scientific Advisory Board for Terray Therapeutics. Elliott earned their M.D. from Yale University School of Medicine in 1987.
This person is not in the org chart
This person is not in any teams
This person is not in any offices